Equity Fundraising in India Tops Rs 1 Lakh Crore Since April 2026 as IPO, QIP and OFS Activity Accelerates

Equity fundraising in Indian capital markets has crossed Rs 1 lakh crore since April 2026, driven by a sharp revival in initial public offerings, qualified institutional placements, offers for sale and block deals. Strong domestic liquidity and improving investor confidence have brought companies and large shareholders back to the primary and secondary fundraising windows in the first quarter of FY27.

The equity fundraising milestone, reached in barely three months of the fiscal year, underlines how quickly risk appetite has recovered, with mutual funds, insurers and foreign investors absorbing large share supplies without disrupting the broader market.

Click Here – Get Free Investment Predictions

What Is Driving the Equity Fundraising Surge

Three forces are at work. First, domestic institutional flows remain heavy: systematic investment plan inflows into equity mutual funds continue at record levels, giving fund managers steady cash that must be deployed, often through large primary issuances rather than the open market. Second, benchmark indices trading near highs make valuations attractive for sellers, encouraging promoters, private equity funds and the government to monetise stakes.

Third, the government’s own divestment programme has been active, with the Union Budget 2026-27 targeting Rs 80,000 crore from divestment and asset monetisation. Offers for sale in public sector companies have followed in quick succession through the fiscal year.

Get Research-Backed Stock Ideas from a SEBI Registered Investment Advisor

Recent Deals Powering the Equity Fundraising Tally

The current week alone illustrates the breadth of activity. The government opened an offer for sale in Cochin Shipyard on 7 July at a Rs 1,400 floor price to divest up to 5.04 percent. Blue Jet Healthcare launched a qualified institutional placement on 6 July with a floor price of Rs 531.70 per share. On the IPO side, SEBI has cleared draft papers of Manipal Health Enterprises and Rentomojo, adding to a deep pipeline of upcoming listings that includes some of the largest issues ever planned in India.

Block deals by private equity investors and promoters have added further equity fundraising volume, with institutional appetite absorbing most large trades at narrow discounts.

What the Equity Fundraising Boom Means for Investors

A heavy equity fundraising calendar cuts both ways. It gives investors access to new businesses and discounted stock through OFS and QIP windows, but persistent supply can cap upside in the secondary market as institutional money rotates from listed shares into new paper. Historically, prolonged phases of heavy equity fundraising have coincided with sideways index behaviour even when flows remain strong.

For retail investors, the practical takeaway is selectivity: quality issuers with reasonable pricing tend to reward participation, while aggressive valuations in crowded fundraising windows have a weaker track record.

Download the Univest iOS App or Univest Android App to track upcoming IPOs, QIPs and OFS deals with daily research on the go.

Conclusion

Equity fundraising in India has topped Rs 1 lakh crore since April 2026 on the back of strong domestic liquidity, active government divestment and a reviving IPO pipeline. With the Cochin Shipyard OFS, the Blue Jet Healthcare QIP and freshly SEBI-approved IPOs from Manipal Health and Rentomojo all in motion, the supply calendar for the rest of FY27 looks packed. Investors should stay selective as issuance accelerates.

Frequently Asked Questions on Equity Fundraising in India

How much equity fundraising has happened in India since April 2026?

Ans. Equity fundraising in Indian capital markets has crossed Rs 1 lakh crore since April 2026, covering IPOs, qualified institutional placements, offers for sale and block deals in the first quarter of FY27.

What is driving the equity fundraising surge in FY27?

Ans. Strong domestic liquidity from record mutual fund inflows, elevated market valuations that encourage sellers, and the government’s Rs 80,000 crore FY27 divestment and asset monetisation programme are the key drivers.

Which recent deals are part of the fundraising wave?

Ans. Recent activity includes the Cochin Shipyard OFS at a Rs 1,400 floor price, the Blue Jet Healthcare QIP at a Rs 531.70 floor, and SEBI approvals for the Manipal Health Enterprises and Rentomojo IPOs.

What is the difference between an IPO, QIP and OFS?

Ans. An IPO is the first sale of shares to the public by an unlisted company. A QIP is a fresh issue of shares by a listed company to institutional investors. An OFS is a sale of existing shares by a large shareholder through the exchange, with no new shares created.

Is heavy equity fundraising good or bad for the stock market?

Ans. Heavy issuance expands investment choice and often comes with discounted pricing, but sustained supply can absorb institutional liquidity and cap secondary market upside, which is why markets often move sideways during peak fundraising phases.

What is the government’s divestment target for FY27?

Ans. The Union Budget 2026-27 set a target of Rs 80,000 crore from divestment and asset monetisation, which the government is pursuing through offers for sale in public sector companies.

Should retail investors participate in IPOs and OFS deals now?

Ans. This article does not constitute investment advice. Participation should be selective, focusing on issuer quality and pricing. Consult a SEBI registered financial advisor before investing.